An additional study sought to characterize MDCSs in CRC and demonstrated that the number of Lin−/lowHLA-DR−CD11b+CD33+ MDSCs in peripheral blood were markedly increased in CRC patients compared to healthy donors. This evidence concerns the gene CD33 and colorectal carcinoma.